Epstein Secrets

oor vote as early as next week. CQ Roll Call <https://www.rollcall.com/2020/09/30/wolf-nomination-for-homeland-security-secretary- advances/> (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced pushback from committee Democrats for his role in implementing controversial

prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human Rights Commission virtual hearing on enforced dis

or." The 6-3 vote in the Homeland Security and Governmental Affairs Committee sets up a full floor vote as early as next week. CO Roll Call (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced pushback from committee Democrats for his role in implementing controversial

prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced dis

r." The 6-3 vote in the Homeland Security and Governmental Affairs Committee sets up a full floor vote as early as next week. CQ Roll Call (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced pushback from committee Democrats for his role in implementing controversial

g prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced di

r." The 6-3 vote in the Homeland Security and Governmental Affairs Committee sets up a full floor vote as early as next week. CQ Roll Call (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced pushback from committee Democrats for his role in implementing controversial

prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced di